National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -4 of 4         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Active


18 to 75


Other


Dathyrca 1
EudrCT 2007-002713-39, HB-2007-043, Data register 2007-41-120, NCT00604318

Last Modified: 7/12/2007     First Published: 12/18/2006  

2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


16 to 80


Other


CRUK-HILO-BRD/05/83
ISRCTN56078540, EU-20665, CTA-20363/0217/001/0001, EUDRACT-2005-003687-37, NCT00415233


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Diagnostic, Supportive care


Active


18 and over


Other


CRC 03-52-R1
NCT00223158


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

No phase specified


Supportive care


Active


18 and over


Other


2005-0804
NCT00488644

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov